Epstein-Barr virus-associated antigens activated in human cells by 5-bromodeoxyuridine.
D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis*; D000956:Antigens, Viral / Q000032:analysis*; D001973:Bromodeoxyuridine / Q000494:pharmacology*; D002051:Burkitt Lymphoma; D002277:Carcinoma / Q000276:immunology; D002460:Cell Line; D003168:Complement Fixation Tests; D005455:Fluorescent Antibody Technique; D005856:Germ-Free Life; D000882:Haplorhini / Q000276:immunology; D004854:Herpesvirus 4, Human / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D007106:Immune Sera; D007244:Infectious Mononucleosis / Q000276:immunology; D007962:Leukocytes; D008251:Macaca / Q000276:immunology; D009303:Nasopharyngeal Neoplasms / Q000276:immunology; D002679:Pan troglodytes / Q000276:immunology
D000914:Antibodies, Viral; D000956:Antigens, Viral; D007106:Immune Sera; D001973:Bromodeoxyuridine